Recombinant Human Osteoactivin/GPNMB Protein, ≥95% (SDS-PAGE), high purity

Features and benefits
  • Expression System: HEK293
  • Accession #: Q14956
  • Protein Tag: C-His
  • Bioactivity: Immobilized Recombinant Human Osteoactivin/GPNMB Protein (rp146610) at 1.0 μg/mL can bind GPNMB Antibody with the EC50 is 129.8 ng/mL.
  • Endotoxin Concentration: <0.1 EU/μg
Item Number
rp146610
Grouped product items
SKUSizeAvailabilityPrice Qty
rp146610-10μg
10μg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$89.90
rp146610-50μg
50μg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$279.90
rp146610-100μg
100μg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$449.90
rp146610-1mg
1mg
Available within 8-12 weeks(?)
Production requires sourcing of materials. We appreciate your patience and understanding.
$2,599.90

Animal Free, ≥95% (SDS-PAGE), Active, 293F, C-His tag, 23-486 aa

Basic Description

Product NameRecombinant Human Osteoactivin/GPNMB Protein, ≥95% (SDS-PAGE), high purity
GradeActiBioPure™, Animal Free, Azide Free, Bioactive, Carrier Free
Product Description

Purity
≥95% SDS-PAGE.
Endotoxin level
<0.1 EU/µg
Function
Could be a melanogenic enzyme.

Specifications & PurityActiBioPure™, Bioactive, Animal Free, Carrier Free, Azide Free, ≥95%(SDS-PAGE)
Purity≥95% (SDS-PAGE)
BioactivityImmobilized Recombinant Human Osteoactivin/GPNMB Protein (rp146610) at 1.0 μg/mL can bind GPNMB Antibody with the EC50 is 129.8 ng/mL.
Endotoxin Concentration<0.1 EU/μg
Expression SystemHEK293
SpeciesHuman
Amino Acids23-486 aa
SequenceKRFHDVLGNERPSAYMREHNQLNGWSSDENDWNEKLYPVWKRGDMRWKNSWKGGRVQAVLTSDSPALVGSNITFAVNLIFPRCQKEDANGNIVYEKNCRNEAGLSADPYVYNWTAWSEDSDGENGTGQSHHNVFPDGKPFPHHPGWRRWNFIYVFHTLGQYFQKLGRCSVRVSVNTANVTLGPQLMEVTVYRRHGRAYVPIAQVKDVYVVTDQIPVFVTMFQKNDRNSSDETFLKDLPIMFDVLIHDPSHFLNYS
Protein TagC-His
Accession #Q14956
Predicted molecular weight53 kDa
SDS-PAGE70 - 100 kDa, under reducing conditions; 70 - 100 kDa, under non-reducing conditions.

Images

Recombinant Human Osteoactivin/GPNMB Protein (rp146610) - Protein Bioactivity
Immobilized Recombinant Human Osteoactivin/GPNMB Protein (rp146610) at 1.0 μg/mL can bind GPNMB Antibody with the EC50 is 129.8 ng/mL.

Recombinant Human Osteoactivin/GPNMB Protein (rp146610) - SDS-PAGE
3 μg/lane of Recombinant Human Osteoactivin/GPNMB Protein was resolved with SDS-PAGE under reducing (R) and non-reducing (N) conditions and visualized by Coomassie® Blue staining, showing a band at 70 - 100 kDa.

Product Specifications

FormLyophilized
ReconstitutionReconstitute in sterile water to a concentration of 0.1-0.5 mg/ml.
Storage TempStore at -80°C,Avoid repeated freezing and thawing
Shipped InIce chest + Ice pads
Stability And StorageStore at -20~-80℃ for more than 1 year. Upon delivery aliquot. Avoid freeze/thaw cycle.

Certificates

Certificate of Analysis(COA)

Enter Lot Number to search for COA:

Related Documents

References

1. Scherer SW, Cheung J, MacDonald JR, Osborne LR, Nakabayashi K, Herbrick JA, Carson AR, Parker-Katiraee L, Skaug J, Khaja R et al..  (2003)  Human chromosome 7: DNA sequence and biology..  Science,  300  (5620): (767-72).  [PMID:12690205]
2. Clark HF, Gurney AL, Abaya E, Baker K, Baldwin D, Brush J, Chen J, Chow B, Chui C, Crowley C et al..  (2003)  The secreted protein discovery initiative (SPDI), a large-scale effort to identify novel human secreted and transmembrane proteins: a bioinformatics assessment..  Genome Res,  13  (10): (2265-70).  [PMID:12975309]
3. Rose AA, Grosset AA, Dong Z, Russo C, Macdonald PA, Bertos NR, St-Pierre Y, Simantov R, Hallett M, Park M et al..  (2010)  Glycoprotein nonmetastatic B is an independent prognostic indicator of recurrence and a novel therapeutic target in breast cancer..  Clin Cancer Res,  16  (7): (2147-56).  [PMID:20215530]
4. Tse KF, Jeffers M, Pollack VA, McCabe DA, Shadish ML, Khramtsov NV, Hackett CS, Shenoy SG, Kuang B, Boldog FL et al..  (2006)  CR011, a fully human monoclonal antibody-auristatin E conjugate, for the treatment of melanoma..  Clin Cancer Res,  12  (4): (1373-82).  [PMID:16489096]
5. Kuan CT, Wakiya K, Dowell JM, Herndon 2nd JE, Reardon DA, Graner MW, Riggins GJ, Wikstrand CJ, Bigner DD.  (2006)  Glycoprotein nonmetastatic melanoma protein B, a potential molecular therapeutic target in patients with glioblastoma multiforme..  Clin Cancer Res,  12  (7 Pt 1): (1970-82).  [PMID:16609006]
6. Weterman, M A MA and 6 more authors..  (1995)  nmb, a novel gene, is expressed in low-metastatic human melanoma cell lines and xenografts..  International journal of cancer,    (3):   [PMID:7814155]
7. Bandari, Persis S PS and 9 more authors..  (2003)  Hematopoietic growth factor inducible neurokinin-1 type: a transmembrane protein that is similar to neurokinin 1 interacts with substance P..  Regulatory peptides,    (28):   [PMID:12609765]
8. Basrur, Venkatesha V and 12 more authors..  ()  Proteomic analysis of early melanosomes: identification of novel melanosomal proteins..  Journal of proteome research,      [PMID:12643545]
9. Chi, An A and 16 more authors..  (2006)  Proteomic and bioinformatic characterization of the biogenesis and function of melanosomes..  Journal of proteome research,      [PMID:17081065]
10. Yang, Chi-Fan CF and 7 more authors..  (2018)  Loss of GPNMB Causes Autosomal-Recessive Amyloidosis Cutis Dyschromica in Humans..  American journal of human genetics,    (1):   [PMID:29336782]

Solution Calculators